SARS-CoV-2 variants of concern (VOC) have arisen independently at multiple locations 1 ,
2 and may reduce the efficacy of current vaccines that target the spike glycoprotein of SARS-…

The emergence of SARS-CoV-2 Omicron, first identified in Botswana and South Africa, may
compromise vaccine effectiveness and the ability of antibodies triggered by previous …

Characterizing SARS-CoV-2 evolution in specific geographies may help predict properties
of the variants that come from these regions. We mapped neutralization of a SARS-CoV-2 …

The emergence of the SARS-CoV-2 variant of concern Omicron (Pango lineage B.1.1.529),
first identified in Botswana and South Africa, may compromise vaccine effectiveness and …

The SARS-CoV-2 Omicron variant (B.1.1.529) has multiple spike protein mutations 1 , 2 that
contribute to viral escape from antibody neutralization 3 , 4 , 5 – 6 and reduce vaccine …

SARS-CoV-2 Omicron (B.1.1.529) BA.4 and BA.5 sub-lineages, first detected in South Africa,
have changes relative to Omicron BA.1 including substitutions in the spike receptor binding …

HIV cerebrospinal fluid (CSF) escape, where HIV is suppressed in blood but detectable in
CSF, occurs when HIV persists in the CNS despite antiretroviral therapy (ART). To determine …

The extent to which Omicron infection 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 – 9 , with or without previous
vaccination, elicits protection against the previously dominant Delta (B.1.617.2) variant is …

Characterizing SARS-CoV-2 evolution in specific geographies may help predict the properties
of variants coming from these regions. We mapped neutralization of a SARS-CoV-2 strain …

The SARS-CoV-2 Omicron (B.1.1.529) variant first emerged as the BA.1 sub-lineage, with
extensive escape from neutralizing immunity elicited by previous infection with other variants, …